28 results about "Nutraceutical" patented technology

The application discloses a personalized pet nutrition and health care product recommendation method and system, and relates to the field of artificial intelligence. The specific steps comprise the following steps: collecting pet related information and labels from multiple source systems; performing normalization and nonlinear interaction feature construction on numerical features, and performing adaptive embedding and category cross on category type features to obtain enhanced original vectors; screening features by using label association information, and performing clustering fusion to obtain a fusion feature matrix; adopting an improved feature cross network, introducing low-rank decomposition and pet health knowledge prior to construct a classification model; constructing a loss function introducing a rule constraint regular term, training the model and updating parameters; and recommending nutrition and health care products to pets by using the trained model. The application can accurately capture the complex relationship between features, and significantly improve the accuracy of model prediction.

The present invention provides a novel room-temperature extraction system and method for cannabis and hemp, utilizing custom membrane filtration to efficiently isolate cannabinoids, terpenes, and other bioactive compounds while reducing energy consumption. This multi-stage system begins with a custom milling machine that preprocesses biomass by separating non-target components, such as cellulose-rich stalks, to improve extraction efficiency. The core extraction process employs a series of custom membranes designed to selectively filter cannabinoids and terpenes, minimizing impurities without the need for traditional sub-zero cooling. Each membrane stage incorporates solvent recovery to recycle ethanol, reducing waste and operational costs. In the final stage, a custom concentrator removes residual ethanol, decarboxylates THCa to THC, and crystallizes sugars to prevent downstream clogging. This room-temperature extraction system significantly enhances yield, purity, and sustainability, making it a scalable and cost-effective solution for cannabis and hemp processing industries, as well as applicable for pharmaceutical and nutraceutical uses.

The invention provides a process for preparing a plasticised superporous hydrogel material comprising subjecting initial hydrogel material to treatment with an acidic solution, an optional treatment with a monovalent metal salt solution, freeze drying and plasticisation. Optionally, the process of the invention produces moulded plasticised superporous hydrogel material bodies that have one or more through-holes formed therein. The plasticised superporous hydrogel material of the present invention may be formulated as a suitable oral dosage form for use an appetite suppressant and for use to deliver a pharmaceutical and / or nutraceutical into a human or animal body.

In an iron (II) citrate monohydrate, identified by the formula FeC6H6O7-H2O ( Ferrous citrate monohydrate or iron citrate (II) monohydrate), obtained according to a particular production method, citric acid and elemental iron are bound in a molecular complex where the iron is agglomerated in the citrate which moves to a cyclic form and the iron is bound to the O groups of the carboxylic groups 1 and 3 through ionic bonds, forming two enantiomers, D and L (R and S), both perfectly water-soluble and highly assimilable by the human body. Formula (L) & Formula (D). With a different absorption mechanism from traditional iron molecules, said iron citrate monohydrate is usable in pharmaceutical and / or nutraceutical and / or food compositions, in particular in the treatment and prevention of iron deficiency anemias and in general of all diseases and disorders associated with iron deficiency. The effectiveness is proven by several examples.

The present disclosure relates to methods, devices and systems for exposing microorganisms or compositions comprising functional proteins to an oscillating electric field substantially free of a magnetic component in order to improve stress responses, survival and metabolite or protein production. In embodiments, a controller drives one or more insulated emitters with a true AC signal or pulsed DC signal, in stepped, swept or shuffled patterns of an electric field oscillating at one or more frequencies in the range 210 Hz to 99 kHz. Exposure to the field provides surmounting energy that enhances protein breathing, catalysis, and fundamental functions of multiprotein complexes including transcription factors and ribosomes, thereby improving stress resistance of microorganisms, their viability during fermentation, drying, storage, transport, and / or increasing production of functional or therapeutic proteins, metabolites or microbial lysates. The technology is applicable to manufacture of probiotics, therapeutics, metabolites, food, alcohol, feed and bioenergy, cosmetics, nutraceuticals and biopharmaceuticals..

The present invention relates to the strain Lactococcus lactis subsp. lactis CECT 31096, to its cellular components, metabolites, and secreted molecules, and to compositions comprising the above products, as well as to their uses as a medicament, preferably for the prevention and / or reduction of hypertension, or as a food composition or nutraceutical.

This invention generally relates to fermentation products of Bifidobacterium animalis subsp. lactis HN019, or parts or derivatives thereof. More specifically, but not exclusively, the invention relates to compositions and methods for maintaining or increasing antioxidant status and / or metabolic health in a subject in need thereof, by administering a composition comprising said fermentation product to the subject. Also provided are methods of producing a fermentation product, pharmaceutical and nutraceutical compositions, and nutritional compositions.

Provided are gamma glutamylcysteine synthetase variants and microbial cells comprising such variants and / or expressing heterologous gamma-glutamylcysteine synthetase-glutathione synthetases, for producing increased amounts of the antioxidant peptide glutathione (GSH). Methods and compositions provided herein may be useful in baking and winemaking applications and in production of nutraceuticals, pharmaceuticals, cosmetics, plant protectants and / or animal feeds.

The application discloses grape skin protein peptides with DPP-IV inhibiting activity and a preparation method thereof, and belongs to the field of comprehensive utilization of grape wine fermentation by-products. The grape skin protein peptides are prepared from the enzymolysis product of grape skin protein prepared from grape skin by an ultrasonic-assisted alkali method through neutral protease enzymolysis. The grape skin protein peptides have good DPP-IV inhibiting effect, are a natural plant source DPP-IV inhibitor, and can be applied to functional food and nutrition health care products.

The processes disclosed are simple, economical for large scale industrial production resulting in high purity and quality of paraxanthine. Further the process produces high-purity paraxanthine suitable for various applications in the nutraceutical, pharmaceutical, and cosmetic industries.

Myogenic compounds identified in egg yolk and synthetic derivatives thereof, nutraceutical compositions of one or more of these myogenic compounds and synthetic derivatives thereof and use of these compounds and nutraceutical compositions in increasing muscle mass in mammals are provided.

Nutraceutical formulations, which could be used for wholistic skin care and treatment purposes, with enhanced organoleptic properties have elements of biological origin more particularly a herbal formulation(s).

A composition for improving female health, sexual performance, and benefiting the gut-brain axis is disclosed. The composition includes sufficient amounts of Black Cohosh Extract 20:1, Black Pepper Pepper Extract (95% piperine), Korean Red Ginseng 8:1, Ginkgo Biloba Leaf 8:1, Horny Goat Weed Extract 8:1, Tribulis Terrestris vine 8:1, Avena Sativa Extract Seed 8:1, Pine Bark Extract 8:1, Muira Pauma Extract 8:1, Lemon Balm P.E. 4:1 (Melissa officinalis folium), Red Raspberry Leaf Extract 4:1, Damiana Leaf Extract 4:1, Butea Superba Root 8:1, Ashwagandha Extract 4:1, L-Arginine HCL Powder, L-Citrulline, a Probiotic Blend, TKA 200, Fermented Green Tea Extract with L-Theanine and Caffeine, Folic Acid, Zinc Aspartate, Vitamin E (D-alpha Tocopheryl Acetate), Vitamin D3, Vitamin C (Ascorbic Acid), Vitamin B12 (Methyl cobalamin), Vitamin B6 (Pyridoxine HCL), Pantothenic Acid (D-Calcium Pantothenate), Vitamin B3 Crystalline Powder (Niacinamide), Vitamin B2 Powder (Riboflavin), Biotin (D-biotin), Vitamin B1 HCl (Thiamine HCL).

Compositions and methods for protecting against a wide spectrum of viral and bacterial infections, including Covid-19, and for treating established infection and infectious inflammation are described. The composition includes a novel combination of vitamins, minerals, nutraceuticals, and phytochemicals, which may be compounded as a pill, tablet, powder, capsule or liquid to be taken orally or via other administration routs one or more times per day, to serve as immune boosters, antibacterial agents, and antiviral agents along with providing anti-inflammatory effects in humans and animals.

Provided are compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, tautomer, enantiomer, diastereomer, or isotopically labeled compound thereof, and pharmaceutical compositions thereof, and uses thereof in the manufacture of medicaments and dietary supplements, nutraceuticals, pet food nutraceuticals, and cosmetics, skin care products for the prevention and treatment of diseases associated with NAD+ reduction due to aging or other causes. Ring A, Ring B, X1, Y1, Y2, Z, R, R0 to R3, n, and m in Formula (I) are as defined in the specification.

A composition comprising or consisting of L-theanine and one or more fructooligosaccharides, wherein the ratio of L-theanine to froctooligosaccharide(s) is of about 2:1 to 99:1. A composition in the form of a food or nutraceutical, and also in the form of a powder, granules, suspension, tablet, capsule, lozenge, bakery item, sweets, drink, beverage or oral preparation.

A system (100) and method (900) for dispensing a personalized nutraceutical (81) to a consumer (62). The system (100) can create the personalized nutraceutical (81) that is selectively influenced by one or more health attributes (640) relating to the intended consumer (62) of the personalized nutraceutical (81). The application(s) (373) of the system (300) can create a variety of outputs (690) including a personalized recipe (693) for the personalized nutraceutical (81) from a variety of inputs (610) that can include the health attributes (640) of the consumer (62). A production assembly (500) can manufacture the personalized nutraceutical (81) using the personalized recipe (693).

The present invention relates to a stable, bioavailable, oral lipophilic nutrient composition comprising RR-zeaxanthin, curcuminoids, and / or lutein, along with nutraceutically acceptable excipients. In particular, the present invention provides a stable, bioavailable liquid oral composition comprising zeaxanthin isomers, curcuminoids, and / or lutein. The stable, bioavailable lipophilic nutrient composition of R, R-zeaxanthin, curcuminoids, and / or lutein is used for ophthalmic care, preferably for age-related eye diseases (AREDS), Age-related Macular degeneration (AMD), Visual dysfunction, Retinopathy, and other Eye diseases and disorders. The present invention further provides a process for preparing a nutraceutically stable and bioavailable lipophilic nutrient composition comprising zeaxanthin isomers, curcuminoids, and / or lutein.

This invention discloses a method for preparing lactoferrin-polyphenol nanocomposites with intestinal immune function. The method involves the following steps: First, lactoferrin is moderately hydrolyzed under the action of a complex protease to optimize its molecular structure. Then, it is compounded with water-soluble polyphenols (such as chlorogenic acid or epicatechin) using metal ion chelation technology, and Ca²⁺ is used to induce lactoferrin bridging and aggregation to form a complex. Next, ultrasonic homogenization is performed to further control the particle size, ensuring it is distributed within the range of 100-300 nm. The resulting complex is then concentrated by nanofiltration and electrostatic spray drying to obtain a structurally stable shell-core nanocomposite, which is then nitrogen-filled to prevent oxidation. The lactoferrin-polyphenol nanocomposite prepared by this invention not only exhibits good stability and intestinal immune-enhancing effects but also significant antibacterial activity, making it widely applicable in functional foods and nutritional supplements.

A biodegradable packaging material and method thereof is provided. The biodegradable packaging materials includes molded items, flexible sheets, and films, derived from agricultural and industrial residues such as used cooking oil, tamarind kernel seed waste, and bamboo dust. The agricultural and industrial residues are formulated using natural binders like cassia gum and xanthan gum, processed through microwave-assisted reactive blending, and converted into bio-pellets via twin- screw extrusion. The biodegradable packaging material is customizable in transparency, fragrance, and flavor, making the biodegradable packaging material ideal for food packaging, consumer goods, and nutraceuticals. The disclosure offers a sustainable, cradle-to-cradle solution, reducing dependency on fossil-based plastics.

Provided are a monascus strain capable of producing monascin and / or ankaflavin and the use thereof. Particularly, provided are a new monascus strain assigned with the accession number CGMCC NO. 41335 and the use thereof in the production of high-content monascin and / or ankaflavin and related products thereof. The strain is Monascus purpureus ZYXQ-2206, can produce potent and non-toxic lipid-lowering ingredients monascin and / or ankaflavin with a high yield, and does not produce harmful and toxic ingredients lovastatin (LOV) and citrinin (CIT). Since excessive intake of LOV can cause serious side effects such as liver and kidney injury and rhabdomyolysis, and excessive intake of CIT can cause toxic responses such as renal tubular dilation and degeneration and necrosis of epithelial cells, the monascus products produced by using the strain can effectively avoid these safety risks, and have extremely high application prospects and market potentials. By screening and optimizing a fermentation process, the monascus strain having high productivity, no toxicity and high functionality is provided, which has significant application value in the fields of development of lipid-lowering functional foods and dietary supplements.

A device for dispensing a fluid substance including: a container (6) of the substance; a measuring cup (2) for dosing the substance; a manual pumping means (3) of the substance from the container (6) to the measuring cup (2); a dispenser (4) of the substance from the measuring cup (2) suitable to allow a user to drink the substance.

The present invention relates to an anabolic nutraceutical formulation that offers, among other improvements : - feed conversion, favoring among others the following points : - weight gain with lower food consumption; - the animals reach the target weight set by the producer early; - a natural product, dosed in tiny quantities of active substance; - the anabolic nutraceutical contains Blatta orientalis; - non-toxic for the animal; - non-toxic for the consumer of this meat; - the meat remains adequately hydrated at the core; - the meat remains palatable, tender, succulent and soft; - administration is easy and occasional; - the consumption of the anabolic formulation optimizes the absorption of the nutrients in the food, as well as tissue oxygenation and, at the same time, increases blood flow; - the distribution of lean tissue is greater; - it improves animal health, which means less morbidity and mortality, resulting in savings for livestock producers; - the breeding mothers remain in optimal body condition during the lactation stage.

The present invention relates to the field of nutraceuticals, in particular to the field of animal nutrition and animal feed. Specifically, the present invention relates to a composition comprising droplets of a vitamin A compound in an aqueous solution of at least 40 wt.-% of lignosulfonate based on the total weight of dry matter of the composition, wherein the droplets of the vitamin A compound exhibit a droplet size D[4,3] in the range of 0.4 to 1 µm. Further, the invention contemplates a method for manufacturing the composition, and a feed additive comprising the composition.

Nutraceutical compositions and methods of their use in treating Caliciviridae family viruses are provided. The viruses can be norovirus or sapovirus. An exemplary nutraceutical composition includes Fagopyrum dibotrys extract. Another nutraceutical composition for treating viral gastroenteritis includes 5, 7, 3′, 4′-tetrahydroxyflavan-3-ol C4-C8 dimers, quercetin, rutin, or a combination thereof. The nutraceutical compositions inhibit or reduce entry of Caliciviridae family viruses into intestinal epithelial cells of the subject.